State Street’s Century Therapeutics IPSC Stock Holding History

State Street’s Portfolio IPSC Stock Details IPSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.52M	Buy	1,843,154 +1,456,431	+377%	+$3.33M	﹤0.01%	3065
2026 Q1	$874K	Buy	386,723 +259,280	+203%	+$545K	﹤0.01%	3517
2025 Q4	$127K	Hold	127,443	–	–	﹤0.01%	4000
2025 Q3	$63.5K	Hold	127,443	–	–	﹤0.01%	4127
2025 Q2	$71.2K	Sell	127,443 -718,778	-85%	-$386K	﹤0.01%	4036
2025 Q1	$403K	Sell	846,221 -6,570	-0.8%	-$4.94K	﹤0.01%	3638
2024 Q4	$861K	Buy	852,791 +15,877	+2%	+$21.6K	﹤0.01%	3516
2024 Q3	$1.43M	Buy	836,914 +57,323	+7%	+$112K	﹤0.01%	3413
2024 Q2	$1.99M	Buy	779,591 +294,373	+61%	+$931K	﹤0.01%	3319
2024 Q1	$2.03M	Buy	485,218 +36,727	+8%	+$155K	﹤0.01%	3274
2023 Q4	$1.49M	Buy	448,491 +1,920	+0.4%	+$3.5K	﹤0.01%	3391
2023 Q3	$893K	Sell	446,571 -8,220	-2%	-$21.9K	﹤0.01%	3558
2023 Q2	$1.44M	Buy	454,791 +85,940	+23%	+$277K	﹤0.01%	3515
2023 Q1	$1.28M	Buy	368,851 +26,180	+8%	+$115K	﹤0.01%	3457
2022 Q4	$1.76M	Buy	342,671 +20,004	+6%	+$189K	﹤0.01%	3416
2022 Q3	$3.19M	Buy	322,667 +53,031	+20%	+$559K	﹤0.01%	3268
2022 Q2	$2.27M	Buy	269,636 +47,603	+21%	+$467K	﹤0.01%	3435
2022 Q1	$2.79M	Buy	222,033 +33,885	+18%	+$449K	﹤0.01%	3440
2021 Q4	$2.98M	Buy	188,148 +39,386	+26%	+$740K	﹤0.01%	3493
2021 Q3	$3.74M	Buy	+148,762	New	+$4.03M	﹤0.01%	3383

Other funds holding IPSC

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

State Street's IPSC Position: Q2 2026 in Review

State Street increased its Century Therapeutics (IPSC) stake by 377% in Q2 2026, buying an estimated $3.33M and bringing the position to 1,843,154 shares worth $4.52M. The position accounts for ﹤0.01% of the portfolio, ranked #3065.

State Street first reported a position in IPSC in Q3 2021 and has held it in 20 quarters since. 99 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

State Street held 1,843,154 shares of Century Therapeutics worth $4.52M as of Q2 2026.
State Street bought 1,456,431 Century Therapeutics shares in Q2 2026, an estimated $3.33M.
Century Therapeutics made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3065 holding.
State Street first reported a position in Century Therapeutics in Q3 2021 and has held it in 20 quarters since.
99 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.